Showing results out of
Ewan Birney, Deputy Director General of EMBL and Director of EMBL-EBI, reveals the key factors that enabled AlphaFold to change the world of biology.
PEOPLE & PERSPECTIVES2022
people-perspectivesperspectivesscience
A new method for the robust analysis of copy number variation and used UK Biobank data to identify links between genome and disease.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
EMBO Director Fiona Watt discusses preprints, data sharing, and evaluation in light of EMBL’s new Open Science policy
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
EMBL announces the release of its new Open Science Policy, contributing to positive culture change across the life sciences.
LAB MATTERS2021
lab-matters
The Chan Zuckerberg Initiative has recognised four EMBL researchers with their most recent awards, showing how tech trailblazers are integral to advancing science and medicine.
EMBL ANNOUNCEMENTSLAB MATTERS2020
embl-announcementslab-matters
Three papers published by EMBL scientists and their collaborators will make it much easier to share and compare information from large-scale proteomics data. The papers are published in Nature Biotechnology on 8 and 26 August. As the quantity of available biological information and the use of…
LAB MATTERS2007
lab-matters
EMBOSS, the European Molecular Biology Open Software Suite, has received a vital funding boost from the UK Biotechnology and Biological Sciences Research Council (BBSRC) that will guarantee its continued maintenance under an open source license for the next three years. This ends two years of…
CONNECTIONSLAB MATTERS2006
connectionslab-matters
No results found